PHASE-II STUDY OF TENIPOSIDE IN ADENOCARCINOMA OF THE LUNG

被引:3
|
作者
SORENSEN, JB [1 ]
BACH, F [1 ]
DOMBERNOWSKY, P [1 ]
HANSEN, HH [1 ]
机构
[1] UNIV COPENHAGEN,HERLEV HOSP,DK-2730 HERLEV,DENMARK
关键词
D O I
10.1007/BF00685166
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A total of 26 evaluable patients with previously untreated, non-resectable adenocarcinoma of the lung were given 80 mg/m2 i.v. teniposide daily for 5 days every 3 weeks. Three partial responses (11%) were obtained that lasted for 12, 11 and 32 weeks, respectively. Leucopenia was the dose-limiting side effect, with WBC counts of < 2 x 10(9)/l being observed in 42% of patients, resulting in one septic death. At the dose and schedule used in the present study, teniposide showed only limited activity in adenocarcinoma of the lung.
引用
收藏
页码:487 / 489
页数:3
相关论文
共 50 条
  • [1] PHASE-II STUDY OF TENIPOSIDE IN SMALL CELL-CARCINOMA OF THE LUNG
    PEDERSEN, AG
    BORK, E
    OSTERLIND, K
    DOMBERNOWSKY, P
    HANSEN, HH
    CANCER TREATMENT REPORTS, 1984, 68 (10): : 1289 - 1291
  • [2] TCNU IN ADENOCARCINOMA OF THE LUNG - A PHASE-II STUDY WITH DIVIDED DOSES
    SORENSEN, JB
    BACH, F
    DOMBERNOWSKY, P
    VIBEPETERSEN, J
    HANSEN, HH
    ANNALS OF ONCOLOGY, 1990, 1 (04) : 299 - 300
  • [3] PHASE-II STUDY OF TENIPOSIDE IN ADVANCED BREAST-CANCER
    BOAS, J
    RASMUSSEN, D
    HANSEN, OP
    ENGELHOLM, SA
    DOMBERNOWSKY, P
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (06) : 463 - 464
  • [4] TENIPOSIDE IN REFRACTORY OVARIAN-CANCER - A PHASE-II STUDY
    SESSA, C
    DINCALCI, M
    LANDONI, F
    COLOMBO, N
    MANGIONI, C
    CANCER TREATMENT REPORTS, 1984, 68 (05): : 815 - 816
  • [5] TENIPOSIDE FOR BRAIN METASTASES OF SMALL-CELL LUNG-CANCER - A PHASE-II STUDY
    POSTMUS, PE
    SMIT, EF
    HAAXMAREICHE, H
    VANZANDWIJK, N
    ARDIZZONI, A
    QUOIX, E
    KIRKPATRICK, A
    SAHMOUD, T
    GIACCONE, G
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) : 660 - 665
  • [6] PHASE-II TRIAL OF VINDESINE IN ADENOCARCINOMA OF THE LUNG
    SLEDGE, GW
    CLARK, GM
    VONHOFF, DD
    CANCER TREATMENT REPORTS, 1984, 68 (03): : 557 - 558
  • [7] A PHASE-II STUDY OF CARBOPLATIN IN ADENOCARCINOMA OF THE ESOPHAGUS
    STEEL, A
    CULLEN, MH
    ROBERTSON, PW
    MATTHEWS, HR
    BRITISH JOURNAL OF CANCER, 1988, 58 (04) : 500 - 501
  • [8] A PHASE-II STUDY OF CARBOPLATIN IN ADENOCARCINOMA OF THE ESOPHAGUS
    STEEL, A
    CULLEN, MH
    ROBERTSON, P
    MATTHEWS, HR
    BRITISH JOURNAL OF CANCER, 1988, 58 (02) : 276 - 276
  • [9] PHASE-II STUDY OF PALA, AMSACRINE, TENIPOSIDE, AND ZINOSTATIN IN SMALL CELL LUNG-CARCINOMA (EST 2579)
    CREECH, RH
    TRITCHLER, D
    ETTINGER, DS
    FERRARO, JA
    RUCKDESCHEL, JC
    VOGL, SE
    WOLL, J
    CANCER TREATMENT REPORTS, 1984, 68 (09): : 1183 - 1184
  • [10] PHASE-II STUDY OF TENIPOSIDE (VM-26) IN MULTIPLE-MYELOMA
    TIRELLI, U
    ZAGONEL, V
    VERONESI, A
    VOLPE, R
    CARBONE, A
    BREMA, F
    GRIGOLETTO, E
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (04): : 329 - 331